Publications by authors named "Moritz Binder"

Claim this Profile
R
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis.
Saurabh Zanwar, Gokce Belge Bilgin, Stephen M Broski, Matthew Thorpe, Cem Bilgin, Moritz Binder

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics, Treatment Responses and Outcomes of Light Chain Multiple Myeloma.
Abiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah, Francis K Buadi, Suzanne R Hayman, Moritz Binder

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal plasma cell features in light chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic response.
Matthew J Rees, Susan Geyer, Binoy Yohannan, Nadia Toumeh, Suheil Albert Atallah-Yunes, Moritz Binder

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AL Amyloidosis: A Real-World Experience with CAR-T Cell Therapy.
Melinda Sy Tan, Rahma Warsame, Ricardo D Parrondo, Eli Muchtar, Taxiarchis V Kourelis, Moritz Binder

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ID2 suppresses multiple myeloma cell proliferation by repressing the activity of the transcription factor TCF3.
Mariateresa Fulciniti, Yao Yao, Tommaso Perini, Jessica Fong Ng, Anaïs Schavgoulidze, Moritz Binder

Blood Cancer Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survival.
Matthew J Rees, Nadia Toumeh, Angela Dispenzieri, Morie Gertz, Binoy Yohannan, Moritz Binder

Amyloid· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6 is a highly prognostic biomarker for POEMS syndrome.
Joselle Cook, Rahma Warsame, Maryam Omar, Francis K Buadi, Nadine Abdallah, Moritz Binder

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocyte Kinetics and Outcomes of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma With Out of Specification Products.
Sarah Dingli, Paul Rothweiler, Moritz Binder, Joselle Cook, Morie A Gertz

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes.
Tamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, Ahauve M Orusa, Shinichiro Suzuki, Moritz Binder

Blood Cancer J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations.
Saurabh Zanwar, Joseph Novak, Wilson Gonsalves, Michael Howe, Esteban Braggio, Moritz Binder

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eliminating the need for sequential confirmation of response in multiple myeloma.
Jean-Sébastien Claveau, Prashant Kapoor, Moritz Binder, Francis Buadi, David Dingli

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis.
Eli Muchtar, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, David Dingli, Moritz Binder

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis.
Elham Askari, Angela Dispenzieri, Francis K Buadi, Suzanne R Hayman, Morie A Gertz, Moritz Binder

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of BCL7A permits IRF4 transcriptional activity and cellular growth in multiple myeloma.
Chandraditya Chakraborty, Srikanth Talluri, Moritz Binder, Eugenio Morelli, Jessica Encinas Mayoral

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ratio of brain to liver glucose activity and disease activity in multiple myeloma.
Sarah Dingli, Paul Rothweiler, Moritz Binder, Joselle Cook, Morie A Gertz

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization.
Jenna R Puttkammer, Jason N Barreto, Chelsee J Jensen, Adrienne N Nedved, Justine L Wilson-Miller, Moritz Binder

JCO Oncol Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosis.
Binoy Yohannan, Matthew Rees, Morie A Gertz, Angela Dispenzieri, Prashant Kapoor, Moritz Binder

Blood Neoplasia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes.
Charalampos Charalampous, Jean-Sebastien Claveau, Prashant Kapoor, Moritz Binder, Francis K Buadi

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of lymphocyte kinetics after chimeric antigen receptor T cell therapy for multiple myeloma.
Sarah Dingli, Paul Rothweiler, Moritz Binder, Joselle Cook, Morie A Gertz

Leukemia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes.
Abiola Bolarinwa, Madhu Nagaraj, Saurabh Zanwar, Nadine Abdallah, P Leif Bergsagel, Moritz Binder

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization.
Jenna R Puttkammer, Jason N Barreto, Chelsee J Jensen, Adrienne N Nedved, Justine L Wilson-Miller, Moritz Binder

JCO Oncol Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capillary leak phenotype as a major cause of death in patients with POEMS syndrome.
Kenzie Lee, Taxiarchis Kourelis, Marcella Tschautscher, Rahma Warsame, Francis Buadi, Moritz Binder

Leukemia· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma.
Saurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, Horatiu Olteanu, Francis Buadi, Moritz Binder

Blood Cancer J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mutant ASXL1-BAP1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia.
Zhen Dong, Hugo Sepulveda, Leo J Arteaga-Vazquez, Chad Blouin, Jenna Fernandez, Moritz Binder

Proc Natl Acad Sci U S A· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mutant ASXL1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia.
Zhen Dong, Hugo Sepulveda, Leo J Arteaga-Vazquez, Chad Blouin, Jenna Fernandez, Moritz Binder

bioRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis